Starting MTX at higher or subcut. doses yields better ACR20 responses. Review of 12 trials & 1,566 pts, shows:
- higher initial MTX 25 mg (but more GI AEs)
- SC MTX more ACR20 resp (85% vs PO 77%)
- MTX non-response, success w/ SC MTX
https://t.co/01PuDpkUIF https://t.co/vXLWEp4srH
Links:
Methotrexate treatment strategies for rheumatoid arthritis: a scoping review on…
https://bit.ly/48QRbPv
Mar-11-2024


